ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals, Inc. (AEGR)

1,97
0,00
( 0,00% )
Mis à jour : 01:00:00

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
1,97
Prix Achat
1,91
Prix Vente
1,97
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
1,97
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

AEGR Dernières nouvelles

Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.

-- Transaction creates strong, diversified rare-disease focused portfolio-- Novelion Therapeutics completes concurrent financing of approximately $22 million -- Company to host conference call...

Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (H...

CAMBRIDGE, Mass., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results

CAMBRIDGE, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hyper...

CAMBRIDGE, Mass., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day

CAMBRIDGE, Mass., Sept. 24, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company focused on the development and commercialization of novel...

Aegerion Pharmaceuticals Appoints Remi Menes as Chief Commercial Officer

CAMBRIDGE, Mass., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

Aegerion Pharmaceuticals Announces Second Quarter 2016 Financial Results

-- Company records $44.5 million in total net product sales Company reiterates 2016 total net product sales guidance of between $130 and $150 million -- CAMBRIDGE, Mass., Aug. 09, 2016...

Cohera Medical, Inc.® Appoints Paul Thomas to its Board of Directors

RALEIGH, N.C., July 25, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today the appointment of Paul...

Aegerion Pharmaceuticals Announces Cost Reduction Plans

CAMBRIDGE, Mass., July 20, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

Update in Lawsuit for Investors in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares announced by Shareholders Foundation

SAN DIEGO, June 21, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending in Massachusetts on behalf of certain purchasers of shares of Aegerion...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

AEGR - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 1,97
What is the 1 year trading range for share price?
has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
HOTHHoth Therapeutics Inc
US$ 2,61
(218,45%)
195,15M
RIMEAlgorhythm Holdings Inc
US$ 0,2564
(77,07%)
527,32M
XTIAXTI Aerospace Inc
US$ 0,1458
(65,68%)
1,48B
DATSDatChat Inc
US$ 3,058
(56,02%)
18,84M
SVMHSRIVARU Holding Ltd
US$ 0,067
(44,71%)
326,81M
SLRNACELYRIN Inc
US$ 2,19
(-37,25%)
6,81M
DHAIDIH Holdings US Inc
US$ 1,9101
(-34,59%)
1M
BOXLBoxlight Corporation
US$ 1,1409
(-32,09%)
4,1M
AMSTAmesite Inc
US$ 2,85
(-29,63%)
388,63k
COEPCoeptis Therapeutics Holdings Inc
US$ 4,98
(-28,96%)
566,03k
XTIAXTI Aerospace Inc
US$ 0,1436
(63,18%)
1,45B
RIMEAlgorhythm Holdings Inc
US$ 0,2531
(74,79%)
522,11M
SVMHSRIVARU Holding Ltd
US$ 0,06685
(44,38%)
322,53M
HOTHHoth Therapeutics Inc
US$ 2,75
(235,53%)
193,36M
CDTConduit Pharmaceuticals Inc
US$ 0,096
(32,78%)
143,27M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock